HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmen Bedia Selected Research

Sphingolipids

2/2013The nonlysosomal β-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells.
1/2013Genetic disorders of simple sphingolipid metabolism.
11/2012Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.
5/2012Sphingolipid modulation: a strategy for cancer therapy.
11/2011Ceramidases in hematological malignancies: senseless or neglected target?
11/2011Regulation of autophagy by sphingolipids.
12/2009Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmen Bedia Research Topics

Disease

11Neoplasms (Cancer)
10/2023 - 04/2007
6Prostatic Neoplasms (Prostate Cancer)
03/2023 - 07/2015
3Melanoma (Melanoma, Malignant)
09/2018 - 08/2011
2Lung Neoplasms (Lung Cancer)
12/2023 - 10/2022
2Hematologic Neoplasms (Hematological Malignancy)
11/2011 - 11/2011
1Glioblastoma (Glioblastoma Multiforme)
10/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2021
1Neoplasm Metastasis (Metastasis)
10/2019
1Infections
02/2016
1Pneumonia (Pneumonitis)
02/2016
1Inborn Genetic Diseases (Disease, Hereditary)
01/2013
1Triple Negative Breast Neoplasms
11/2012
1Breast Neoplasms (Breast Cancer)
11/2012
1Starvation
11/2011
1Farber Lipogranulomatosis
12/2010
1Carcinogenesis
12/2009

Drug/Important Bio-Agent (IBA)

7SphingolipidsIBA
02/2013 - 12/2009
5CeramidesIBA
02/2013 - 12/2010
4Aldrin (Isodrin)IBA
03/2023 - 07/2015
4Acid CeramidaseIBA
11/2011 - 04/2007
3LipidsIBA
12/2023 - 07/2015
3Endocrine DisruptorsIBA
03/2023 - 07/2015
2GangliosidesIBA
10/2019 - 11/2011
2Proteins (Proteins, Gene)FDA Link
02/2016 - 11/2011
2CeramidasesIBA
11/2011 - 08/2011
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
11/2011 - 12/2009
11-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022
1Polyethylene (Polythene)IBA
01/2022
1MicroplasticsIBA
01/2022
1Polychlorinated Biphenyls (PCBs)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
05/2021
1Prostate-Specific Antigen (Semenogelase)IBA
05/2021
1glucose-regulated proteinsIBA
10/2019
1PesticidesIBA
03/2018
1ketodihydrosphingosineIBA
04/2016
1Type IV Secretion SystemsIBA
02/2016
1SphingosineIBA
02/2016
1Triglycerides (Triacylglycerol)IBA
12/2015
1Chlorpyrifos (Lorsban)IBA
07/2015
1Chlorodiphenyl (54% Chlorine)IBA
07/2015
1GlucosidasesIBA
02/2013
1GlycosphingolipidsIBA
02/2013
1GlycolipidsIBA
02/2013
1Glucosylceramides (Glucocerebrosides)IBA
02/2013
1HydrolasesIBA
02/2013
1N-caproylsphingosineIBA
11/2012
1Hormones (Hormone)IBA
11/2012
1Estrogen ReceptorsIBA
11/2012
1TamoxifenFDA LinkGeneric
11/2012
1Estrogen Receptor Modulators (Antiestrogen)IBA
11/2012
1Antineoplastic Agents (Antineoplastics)IBA
05/2012
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
05/2012
1EnzymesIBA
08/2011
1Dacarbazine (DIC)FDA LinkGeneric
08/2011
1LyasesIBA
12/2009
1Cytostatic AgentsIBA
04/2007

Therapy/Procedure

4Drug Therapy (Chemotherapy)
11/2011 - 04/2007
3Therapeutics
10/2023 - 05/2012
1Photochemotherapy (Photodynamic Therapy)
10/2023